Who’s in charge of PM identity?
The plasma membrane, or PM, is the front line of cellular life. It functions simultaneously as a border, logistical hub, communications relay and structural foundation. These functions are performed by proteins embedded in or attached to the PM. Typically, these proteins are controlled from the cytosolic face of the PM, enabling the cell to maintain executive control of PM function and adapt it as necessary.

Controlling these PM proteins poses a unique challenge in eukaryotes; the proteins must be targeted correctly and activated at the PM and not at the many other membrane organelles connected by vesicular traffic. For example, a calcium channel should not become activated after synthesis in the endoplasmic reticulum, nor should machinery tasked with pulling vesicles from the PM pull them from endosomes instead. In short, the PM needs a unique chemical identity that proteins can recognize.
We now know that lipids are critical to PM identity. In fact, the cytosolic face of the PM is uniquely enriched in anionic lipids, making the inner leaflet of the PM a distinct, negatively charged electrostatic platform. This attracts peripheral proteins with amphipathic domains, such as small GTPases and protein kinases. It also facilitates activation of membrane proteins, such as channels and transporters, as they arrive at the PM. This electrostatic code appears conserved across the kingdoms of Eukarya, though the lipids involved differ. Phosphatidylserine, or PS, is crucial in all kingdoms but is augmented by other anionic lipids, especially the phosphoinositides — highly charged phospho-derivatives of the anionic lipid phosphatidylinositol, or PI. In animals, the enrichment of PS together with phosphoinositides PIP2 and PI4P is central to PM identity. In plants, PS is instead augmented by PI4P and phosphatidic acid.
Electrostatics play a role in identifying membranes elsewhere in the endocytic network, with decreasing concentrations of anionic lipid the further into the system we venture from the PM. The big question is, How is this gradient of anionic lipids built and maintained?
Fundamental mechanisms are still debated. For example, the extent to which vesicular traffic helps or hinders is not clear. On the one hand, selective sorting of lipids into vesicular carriers could enrich packets of anionic lipid destined for the PM. Alternatively, failure to sort efficiently would instead lead to equilibration of lipids between organelles. Side-stepping vesicular traffic altogether, non-vesicular lipid transport by lipid-binding proteins is an attractive mechanism to facilitate asymmetric lipid distribution in the cell. However, researchers have questioned whether these proteins truly transport lipids from one organelle to another to build or maintain such gradients.
One class of lipid — the phosphoinositides — seems likely to be central to either mechanism. Lipid kinases and phosphatases stationed throughout the PM and endocytic network convert the phospho-configuration of PI as it shuttles between compartments by vesicular traffic, effectively modifying its charge profile. These lipids also control many of the candidate lipid transfer proteins. For example, PM PIP2 was recently shown to control the non-vesicular traffic of the other anionic PM lipids PS and PI4P, suggesting a cardinal role for this lipid in animal-cell PM identity.
While we continue to debate these mechanisms, a key component is still missing: a sensing mechanism to enable homeostatic control of PM anionic lipid content. Such a sensor would be required to activate lipid import and shut if off once the appropriate electrostatic potential is reached. What is the nature of this sensor? Perhaps it controls the abundance of a master lipid like PIP2, which in turn controls traffic of other anionic species. Or perhaps a protein senses the electrostatic potential of the inner leaflet and engages transport.
There is still much for us to learn.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.